TY  - CHAP
M1  - Book, Section
TI  - Myasthenia Gravis and Other Diseases of the Neuromuscular Junction
A1  - Drachman, Daniel B.
A1  - Amato, Anthony A.
A2  - Kasper, Dennis
A2  - Fauci, Anthony
A2  - Hauser, Stephen
A2  - Longo, Dan
A2  - Jameson, J. Larry
A2  - Loscalzo, Joseph
PY  - 2014
T2  - Harrison's Principles of Internal Medicine, 19e
AB  - Myasthenia  gravis  (MG)  is  a  neuromuscular  disorder  characterized  by  weakness  and  fatigability  of  skeletal  muscles.  The  underlying  defect  is  a  decrease  in  the  number  of  available  acetylcholine  receptors  (AChRs)  at  neuromuscular  junctions  due  to  an  antibody-mediated  autoimmune  attack.  Treatment  now  available  for  MG  is  highly  effective,  although  a  specific  cure  has  remained  elusive.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2022/06/25
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1128503226
ER  -